Skip to main content
Eunice Wang, MD, Oncology, Buffalo, NY

EuniceWangMD

Oncology Buffalo, NY

Hematologic Oncology

Chief, Clinical Leukemia Service and Professor of Oncology, Dept Medicine, Roswell Park Cancer Institute; Associate Professor, Dept Medicine, University of Buffalo (UB) SUNY School of Medicine; and Associate Director, UB/RPCI Hematology-Oncology Fellowship

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

  • Office

    Elm and Carlton St
    Buffalo, NY 14263
    Phone+1 716-845-2300
    Fax+1 716-845-8741

Summary

  • I am a hematologist-oncologist and physician scientist whose clinical practice focuses on the treatment of patients with acute and chronic leukemia, myeloid disorders, and benign hematological conditions.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center1999 - 2003
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1997 - 1999
  • Keck School of Medicine of the University of Southern California
    Keck School of Medicine of the University of Southern CaliforniaClass of 1996
  • Harvard University
    Harvard UniversityBA, Biology, Cum Laude, 1987 - 1991

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1999 - 2025

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • NF1 Mutations Are Recurrent in Adult Acute Myeloid Leukemia and Confer Poor Outcome  
    Eunice S Wang, Bayard L Powell, Richard M Stone, John C Byrd, Clara D Bloomfield, Alice Mims, Andrew J Carroll, Jonathan E Kolitz, James S Blachly, Nature

Abstracts/Posters

  • Mitophagy Plays a Key Role in the Anti-Leukemic Activity of Autophagy Inhibitors Under Hypoxia in Acute Myeloid Leukemia
    Eunice S. Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Safety, Efficacy and Biomarker Analysis of a Phase 1b/2 Study of Onvansertib (ONV), a Polo-like Kinase 1 (PLK1) Inhibitor, in Combination with Low-Dose Cytarabine (LDA...
    Eunice S. Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • The 2017 European Leukemianet Genetic Risk Classification Performs Poorly in Older Patients with Acute Myeloid Leukemia (AML) and Should be Refined to Identify Patient...
    Eunice S. Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Tolerability and Efficacy of Crenolanib and Cytarabine/Anthracycline Chemotherapy in Older Patients (Aged 61 to 75) with Newly Diagnosed FLT3-Mutated Acute Myeloid Leu... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • AML: Expert Guidance on Current Standards and New Directions in Patient Care 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid L... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Study Highlights Promising New Treatment Option for Patients with Treatment-Resistant Acute Myeloid Leukemia
    Study Highlights Promising New Treatment Option for Patients with Treatment-Resistant Acute Myeloid LeukemiaOctober 1st, 2024
  • Biomarker Uncovered by Roswell Park Team Identifies NET Patients Likely to Have Blood Side Effects from PRRT
    Biomarker Uncovered by Roswell Park Team Identifies NET Patients Likely to Have Blood Side Effects from PRRTJune 9th, 2021
  • Roswell Park Researchers Gear up for ASCO 2021 Annual Meeting
    Roswell Park Researchers Gear up for ASCO 2021 Annual MeetingJune 3rd, 2021
  • Join now to see all

Committees

  • Member, Scientific Review Committee 2009 - Present
  • Member, Fellowship Program Committee 2007 - Present

Professional Memberships